[CQM-5480] eCQM 108 VTE Medication Prophylaxis Medications Created: 08/01/22  Updated: 08/16/22  Resolved: 08/16/22

Status:

Closed

Project:

eCQM Issue Tracker

Component/s:

None

Type:

EH/CAH eCQMs

Priority:

Moderate

Reporter:

Susan Luca

Assignee:

Mathematica EH eCQM Team

Resolution:

Answered

Votes:

0

Labels:

None

Solution:

​​Thank you for you inquiry. You are correct, Apixaban is NOT listed in the value set as a medication for VTE prophylaxis. We continuously monitor FDA approved indications for medications included in the value set, e.g., apixaban. At this time, there is no approved indication to use apixaban for venous thromboembolism (VTE) prophylaxis and treatment. Please see FDA package insert list of approved indications https://packageinserts.bms.com/pi/pi_eliquis.pdf. Meanwhile, if you have a new announcement, please forward it to us.
For the scenario provided, patients on Apixaban for management of Atrial Fibrillation before and during hospitalization, would meet the following numerator condition, assuming a history of Atrial Fibrillation diagnosis is documented:

"Encounter with Medication Oral Factor Xa Inhibitor Administered on Day of or Day After Admission or Procedure"
      intersect ( "Encounter with Prior or Present Diagnosis of Atrial Fibrillation or Prior Diagnosis of VTE"

Solution Posted On:

Impact:

Question, regarding Eliquis or Apixaban medications

We cannot find Eliquis or Apixaban listed in the value set as a medication for VTE prophylaxis. In the eCQMs we have patients who are admitted on Apixaban as treatment for Atrial Fibrillation, and this medication is continued during their hospitalization to prevent serious blood clots. This causes the patient to fail the measure. Will you be updating the medication value set to include Apixaban or Eliquis? If you do not, this preferred method of treatment which is used as a continuing medication is going to lead to erroneous failures.

Comment by Mathematica EH eCQM Team [ 08/02/22 ]

Thank you for submitting your question. We will review your ticket and provide a response as soon as possible.

Comment by Mathematica EH eCQM Team [ 08/09/22 ]

We continue to investigate the issue noted in your ticket and will provide a response as soon as we are able. Thank you for your patience.